Chrna5-Expressing Neurons in the Interpeduncular Nucleus Mediate Aversion Primed by Prior Stimulation or Nicotine...

Area of Science:

• Neuroscience
• Genetics
• Pharmacology

Background:

• Genetic variations in the CHRNA5/A3/B4 gene locus are linked to smoking behavior.
• The α5 nicotinic acetylcholine receptor subunit is specifically implicated due to coding variants in CHRNA5.
• The conserved Chrna5/a3/b4 locus in rodents and restricted subunit expression suggest neural pathways for nicotine's effects.

Purpose of the Study:

• To investigate the role of α5-containing neurons in the interpeduncular nucleus (IP) in mediating nicotine's effects.
• To determine the functional consequences of α5 subunit deletion on IP neuron responses and behavior.
• To explore the potential impact of CHRNA5 risk variants on smoking drive via nicotine aversion.

Main Methods:

• Electrophysiological recordings in α5-null mice to assess IP neuron responses to nicotinic stimulation.
• Generation of Chrna5-Cre transgenic mice using BAC recombineering to track Chrna5 expression.
• Optogenetic stimulation of Chrna5-expressing IP neurons in mice, with and without prior nicotine exposure or stimulation.

Main Results:

• Electrophysiological responses to nicotinic stimulation were significantly reduced in the IP of α5-null mice.
• Chrna5 expression in IP neurons is independently regulated from Chrna3/b4 genes and these neurons are GABAergic, projecting to mesopontine targets.
• Optogenetic stimulation of Chrna5-expressing IP neurons induced aversion, but only after priming with prior stimulation or nicotine exposure.

Conclusions:

• The α5 subunit plays a critical role in mediating nicotine's cellular effects within the interpeduncular nucleus.
• Chrna5-expressing IP neurons, when activated, can elicit aversive responses to nicotine, contingent on prior exposure.
• The smoking-associated risk allele of CHRNA5 may enhance the drive to smoke by diminishing IP-mediated nicotine aversion.